Does innovation in obesity drugs affect stock markets?: An event study analysis ¿La innovación en medicamentos contra la obesidad afecta a los mercados de valores?: Un análisis de estudio de eventos

Does innovation in obesity drugs affect stock markets?: An event study analysis ¿La innovación en medicamentos contra la obesidad afecta a los mercados de valores?: Un análisis de estudio de eventos

Objective: This study empirically analyzes the effects of public information about the pharmaceutical R&D process on the market valuation of the sponsoring firm. We examined the market's response to scientific news and regulatory decisions about an antiobesity drug, rimonabant, and the effe...

Full description

Bibliographic Details
Main Authors: Jorge V. Pérez-Rodríguez, Beatriz González López-Valcárcel
Format: Article
Language:English
Published: Elsevier 2012-08-01
Series:Gaceta Sanitaria
Subjects:
Rentabilidades anormales
Estudio de eventos
Modelo de mercado
Medicamentos
Obesidad. I+D
Innovación farmacéutica
Abnormal returns
Event study
Market model
Obesity drugs
R & D
Drug innovation
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112012000400010

Internet

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112012000400010

Similar Items